Xanthine Oxidase (XO) is an enzyme that plays a key role in purine metabolism, converting hypoxanthine to xanthine and then to uric acid. Inhibitors of XO, such as allopurinol, are widely used in the treatment of gout and hyperuricemia by reducing uric acid levels in the blood. XO inhibitors are also being explored for their potential benefits in cardiovascular diseases and oxidative stress-related conditions. At CymitQuimica, we provide a variety of XO inhibitors to support your research in metabolic disorders, cardiovascular health, and therapeutic development.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.